Search Results - Andrea Rodríguez-Lopez

Use of Exposure Data to Establish Causality in Drug-Adverse Event Relationships: An Example with Desvenlafaxine by Andrea Rodríguez-Lopez, Gina Mejía-Abril, Pablo Zubiaur, Sofía Calleja, Manuel Román, Francisco Abad-Santos, Dolores Ochoa

Connect to this object online.

Evaluation of the role of metabolizing enzymes and transporter variants in ezetimibe pharmacokinetics by Eva González-Iglesias, Eva González-Iglesias, Dolores Ochoa, Dolores Ochoa, Marcos Navares-Gómez, Pablo Zubiaur, Pablo Zubiaur, Marina Aldama, Tamara de la Torre, Marta de los Ríos-Rodríguez, Paula Soria-Chacartegui, Paula Soria-Chacartegui, Andrea Rodríguez-Lopez, Andrea Rodríguez-Lopez, Francisco Abad-Santos, Francisco Abad-Santos, Francisco Abad-Santos, Jesús Novalbos

Connect to this object online.

Genetic Variation in <i>CYP2D6</i>, <i>UGT1A4</i>, <i>SLC6A2</i> and <i>SLCO1B1</i> Alters the Pharmacokinetics and Safety of Mirabegron by Paula Soria-Chacartegui, Patricia Cendoya-Ramiro, Eva González-Iglesias, Samuel Martín-Vílchez, Andrea Rodríguez-Lopez, Gina Mejía-Abril, Manuel Román, Sergio Luquero-Bueno, Dolores Ochoa, Francisco Abad-Santos

Connect to this object online.

An Investigational Study on the Role of <i>CYP2D6</i>, <i>CYP3A4</i> and <i>UGT</i>s Genetic Variation on Fesoterodine Pharmacokinetics in Young Healthy Volunteers by Andrea Rodríguez-Lopez, Dolores Ochoa, Paula Soria-Chacartegui, Samuel Martín-Vilchez, Marcos Navares-Gómez, Eva González-Iglesias, Sergio Luquero-Bueno, Manuel Román, Gina Mejía-Abril, Francisco Abad-Santos

Connect to this object online.

Genetic variation in UGT1A1 is not associated with altered liver biochemical parameters in healthy volunteers participating in bioequivalence trials by Eva González-Iglesias, Dolores Ochoa, Manuel Román, Paula Soria-Chacartegui, Samuel Martín-Vilchez, Marcos Navares-Gómez, Alejandro De Miguel, Pablo Zubiaur, Andrea Rodríguez-Lopez, Francisco Abad-Santos, Francisco Abad-Santos, Jesús Novalbos

Connect to this object online.